CN201617977U - Stub pin type lacrimal passage support - Google Patents

Stub pin type lacrimal passage support Download PDF

Info

Publication number
CN201617977U
CN201617977U CN2009202712359U CN200920271235U CN201617977U CN 201617977 U CN201617977 U CN 201617977U CN 2009202712359 U CN2009202712359 U CN 2009202712359U CN 200920271235 U CN200920271235 U CN 200920271235U CN 201617977 U CN201617977 U CN 201617977U
Authority
CN
China
Prior art keywords
support
lacrimal passage
lacrimal
pin type
micropores
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009202712359U
Other languages
Chinese (zh)
Inventor
周常波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009202712359U priority Critical patent/CN201617977U/en
Application granted granted Critical
Publication of CN201617977U publication Critical patent/CN201617977U/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Abstract

The utility model relates to a stub pin type lacrimal passage support, comprising a soft hollow support, a spherical expansion part, micropores and a smooth obtuse blind end arranged on the support, wherein the support selects high polymer material having good compatibility with biological tissue, the outer diameter of the selected high polymer material is 0.7-1.2mm, the inner diameter thereof is 0.5-1.0mm, the length thereof is 35-45mm and is approximately the length of the lacrimal passage at one side of a patient; one end of the support is spherically expanded, the diameter thereof is 1.5-2.5mm, the center thereof is provided with the micropores and is communicated with a support trunk; the other end of the support is designed to be the smooth obtuse blind end; and the support trunk is provided with three micropores which are respectively distributed at the places of being 3mm, 15mm, and 25mm from the blind end and have the same aperture of 0.5-1.0mm. The stub pin type lacrimal passage support can be used in the ophthalmology department for treating blockage, stenosis or fracture of the lacrimal passage.

Description

Stud formula lacrimal stent
Technical field this utility model relate to a kind of be used for the ophtalmic treatments obstructed lacrimal passage, narrow or the fracture the soft hollow sting of interim lacrimal passage.
Background technology ophtalmic treatments obstructed lacrimal passage, method narrow or fracture mainly are to adopt interim lacrimal stent to implant, and remove lacrimal stent more then after after a while lacrimal passage is shaped and cure.The various lacrimal stents of development are mainly implanted by three kinds of modes at present: one, from descending puncta or going up puncta to the single pathway of the direct motion of nose lacrimal passage opening and implant lacrimal stent, advantage is to implant just letter, shortcoming is: 1, the fixing difficulty of support, the normal adhesive tape sticking that adopts causes that support comes off, skin allergy etc.; 2, influence is attractive in appearance, and the patient is difficult to accept; 3, easily cause puncta to turn up or chap.Its two, from the nose lacrimal passage opening part implant frame that drives in the wrong direction, advantage is not influence outward appearance, shortcoming is: 1, implant difficulty, require the ophthalmologist to grasp the part technology of department of otorhinolaryngology specialty; 2, easy damaged nasal mucosa; 3, the support of most types can only be treated nasolacrimal passage obliteration, and is invalid to obstruction of lacrimal canaliculus.They are three years old, the stealthy lacrimal stent of two pathwaies, advantage: operation is letter just, can take into account full lacrimal passage and be shaped, and keeps puncta dissect physiology position, do not damage nasal mucosa, be convenient to the lacrimal passage administration, the support fixation does not influence outward appearance, shortcoming: can't visit when logical when a side obstruction of lacrimal canaliculus, " one " listed shortcoming just occur.
Summary of the invention this utility model has overcome the deficiency that above-mentioned lacrimal stent exists, lacrimal stent is implanted had following advantage: operation is letter just, can take into account the omnidistance shaping of a side lacrimal passage, keep puncta dissect physiology position, do not damage nasal mucosa, be convenient to the lacrimal passage administration, support is fixing more firm, substantially not influencing outward appearance, is replenishing of the stealthy lacrimal stent of two pathwaies.
The technical scheme that its technical problem that solves this utility model adopts is: select the soft hollow sting of compatible good macromolecular material for use with biological tissue, and external diameter 0.7~1.2mm, internal diameter 0.5~1.0mm, length is about the length 35~45mm of patient's one side lacrimal passage; Support one end sphere is expanded, diameter 1.5~2.5mm, and there is micropore in central authorities, and communicate with the support trunk; The support other end is designed to smooth blunt shape cecum; The support trunk has 3 micropores, is distributed in apart from cecum and is respectively 3mm, 15mm, 25mm place, and the aperture is all 0.5~1.0mm mutually.
The beneficial effects of the utility model are, make the just letter of lacrimal stent implant procedure, can take into account that a side lacrimal passage is omnidistance to be shaped, keep puncta dissect physiology position, do not damage nasal mucosa, be convenient to the lacrimal passage administration, support is fixing more firm, does not influence outward appearance substantially, is replenishing of the stealthy lacrimal stent of two pathwaies.
Description of drawings Fig. 1 is this utility model structural representation; Fig. 2 is that this utility model is implanted patient's lacrimal passage sketch map.
Among Fig. 1, central micropore (1), sphere is expanded (2), soft hollow sting (3), micropore (4,5,6), smooth blunt shape cecum (7).
Among Fig. 2, lacrimal ductule (8), lachrymal sac (9), nasolacrimal duct (10), stud formula lacrimal stent (11).
The specific embodiment further elaborates this utility model below in conjunction with accompanying drawing
For suffering from obstructed lacrimal passage, narrow or rupture patient, after the method for having known with those skilled in the art is visited logical lacrimal passage earlier, No. 5 hollow lacrimal probes to using always then insert sphere and expand portion's central authorities' micropores (1) to smooth blunt shape cecum (7), implant stud formula lacrimal stent (3) to nose lacrimal passage opening from the probing of lacrimal passages method that puncta has been known by those skilled in the art, this moment, the sphere portion of expanding just contacted puncta, limit bracket slips into lacrimal passage, after the confirmation of micropore (6) water filling water conservancy diversion, extract hollow lacrimal probe No. 5, promptly finishing support implants, can also regularly expand central micropore (1) flushing lacrimal passage according to the state of an illness at ordinary times by sphere, and can be through micropore (4,5,6) water conservancy diversion medicinal liquid treatment.
Facts have proved the probing of lacrimal passages method implant frame that the whole implantation process of this utility model all adopts the ophthalmologist to know, do not require that the ophthalmologist grasps the technology of otorhinolaryngology specialty, thus easy and simple to handle quick, accepted by ophthalmologist and patient easily.

Claims (5)

1. stud formula lacrimal stent is characterized in that: comprise that soft hollow sting and the sphere of design on support expand portion, micropore and smooth blunt shape cecum.
2. stud formula lacrimal stent according to claim 1 is characterized in that: support is the compatible good macromolecular material of biological tissue, external diameter 0.7~1.2mm, internal diameter 0.5~1.0mm, length 35~45mm.
3. stud formula lacrimal stent according to claim 1 is characterized in that: support one end sphere is expanded the diameter 1.5~2.5mm of portion, and there is micropore in central authorities, communicate with the support trunk.
4. stud formula lacrimal stent according to claim 1 is characterized in that: each micropore of support trunk is distributed in apart from cecum and is respectively 3mm, 15mm, 25mm place, and the aperture is all 0.5~1.0mm mutually.
5. stud formula lacrimal stent according to claim 1 is characterized in that: support one end is designed to smooth blunt shape cecum.
CN2009202712359U 2009-11-25 2009-11-25 Stub pin type lacrimal passage support Expired - Fee Related CN201617977U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009202712359U CN201617977U (en) 2009-11-25 2009-11-25 Stub pin type lacrimal passage support

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009202712359U CN201617977U (en) 2009-11-25 2009-11-25 Stub pin type lacrimal passage support

Publications (1)

Publication Number Publication Date
CN201617977U true CN201617977U (en) 2010-11-03

Family

ID=43021428

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009202712359U Expired - Fee Related CN201617977U (en) 2009-11-25 2009-11-25 Stub pin type lacrimal passage support

Country Status (1)

Country Link
CN (1) CN201617977U (en)

Similar Documents

Publication Publication Date Title
JP5524841B2 (en) Lacrimal implant and related methods
CN102481404B (en) Ocular implants
CN104936553B (en) Capsule expander devices for inhibiting capsular opacification and stabilizing the capsule
CN104768505B (en) For treating the eye ring support that iridocorneal angle narrows
JP2011519301A5 (en)
ES2642584T3 (en) Device to drain fluids and reduce intraocular pressure
ES2797776T3 (en) An ophthalmic surgical device
JP5788459B2 (en) Intraocular graft
ES2733442T3 (en) Device for treatment of retinal detachment and other eye diseases
RU2008143224A (en) IMPLANTS OF A NACOLACRIMA DRAINAGE SYSTEM FOR MEDICINAL THERAPY
CN101322663A (en) Intraocular lens with iris diaphragm
CN102824238A (en) Schlemm tube expansion bracket and combined body thereof
CN201127656Y (en) Double pathway invisible lacrimal passage bracket
CN100415190C (en) Novel aqueous humor drainage device for glaucoma
EP2633839A2 (en) Balloon punctal plug
CN201029958Y (en) Non-penetrating integrated artificial cornea
CN101049270B (en) Bracket of vitreous body cavity for curing retina disease, and manufacturing method
EP3442484B1 (en) Lacrimal stent with opening
CN106983596B (en) Lacrimal passage indwelling tube
CN201617977U (en) Stub pin type lacrimal passage support
CN205094680U (en) Intraocular lens suitable for ligamentopexis between wicresoft sclera layer
CN208926788U (en) Three chambers, the two capsule Lacrimal passage tube for obstruction of lacrimal passage of adjustable expansion
CN2863041Y (en) Aqueous humor drainage device for new type glaucoma
CN102599992A (en) Artificial lens with iris diaphragm
CN201200535Y (en) Periodically degrading type tear drainage rebuilding system

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101103

Termination date: 20121125